Going ‘nano’ on Parkinson’s disease in Mexico

The Center for Research and Advanced Studies (Cinvestav) is a national leader in scientific research, technology development and the formation of highly educated professionals in Mexico. Cinvestav is now expanding its reach globally with a nanoparticle-based therapy for Parkinson’s disease that represents an opportunity for international partnerships. To download the full article, please sign in.

Like Comment
Page of
Go to the profile of Cinvestav


The Cinvestav was created in 1961 by presidential decree as a public agency with legal personality and its own assets. Its founding director, Dr. Arturo Rosenblueth, prompted a formal demand that has resulted in the success of the institution. The Cinvestav has twenty-eight research departments that are distributed by the nine campuses throughout Mexico.

No comments yet.